EPND-12. TYROSINE KINASE INHIBITORS AXITINIB, IMATINIB AND PAZOPANIB ARE SELECTIVELY POTENT IN EPENDYMOMA

Reproducibly effective chemotherapy has yet to be identified for ependymoma (EPN), partly due to a lack of models for preclinical drug screening. Treatment of EPN has therefore changed little over the last 40 years and is essentially limited to surgery and radiation. Recurrence risk is high, particu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Donson, Andrew, Werner, Elliot, Amani, Vladimir, Griesinger, Andrea, Witt, Davis, Nellan, Anandani, Vibhakar, Rajeev, Hankinson, Todd, Handler, Michael, Dorris, Kathleen, Foreman, Nicholas
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475033/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.070
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk